Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia

Drugs that substantially, but not exclusively, lower TG and TG-rich lipoprotein cholesterol may have cardiovascular benefits in individuals with elevated TG, particularly if accompanied by low HDL-C.